On November 6, the internationally renowned journal Nature Communications published the research results of Professor Chen Zhong’s team at ZCMU, titled “Pathogenesis-adaptive polydopamine nanosystem for sequential therapy of ischemic stroke”. The team has long been engaged in research on brain diseases. In recent years, the team has focused on developing new targets and strategies for treating chronic neurological diseases such as ischemic brain injury and epilepsy. Their research has accomplished fruitful results: Cell Reports, 2023; Signal Transduct. Tar., 2023a, b, c; Ann. Neurology, 2023; PNAS, 2023a,b; Cell Reports, 2022; Nat. Commun., 2022a,b; Ann. Neurology, 2021; Nat. Commun., 2021; Nat. Nanotech, 2020.
The first author of this study is Researcher Wu Di from ZCMU, with Zhou Jing, a teacher from ZCUM, and Researcher Zheng Yanrong as co-first authors, and Chen Zhong and Wu Di as co-corresponding authors.
International Relations Office
Tel: 86-571-86613545
Email: international@zcmu.edu.cn
International Education College
Tel: 86-571-86613649
Email: admission@zcmu.edu.cn
Address: No. 548 Binwen Road, Binjiang District, Hangzhou City, Zhejiang Province(310053)
Copyright ? Zhejiang Chinese Medical University
浙ICP备05040830-1号 浙公网安备 33010802003603号